TFX
Teleflex Incorporated NYSE Listed Mar 17, 1980$127.00
+1.63%
vs $124.96
Mkt Cap $5.6B
52w Low $100.18
67.9% of range
52w High $139.67
50d MA $129.33
200d MA $120.24
P/E (TTM)
-6.3x
EV/EBITDA
25.9x
P/B
1.8x
Debt/Equity
0.9x
ROE
-22.9%
P/FCF
23.1x
RSI (14)
47.60
ATR (14)
$3.76
Beta
0.83
50d MA
$129.33
200d MA
$120.24
Avg Volume
663.2K
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
550 East Swedesford Road · Wayne, PA 19087-1603 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | BMO | — | — | — | 123.23 | +5.2% | +6.9% | +1.0% | -2.5% | -0.5% | +0.8% | — |
| Feb 26, 2026 | BMO | 3.73 | 1.93 | -48.3% | 111.89 | -3.0% | +6.4% | +2.6% | +0.7% | -0.6% | -2.5% | — |
| Nov 6, 2025 | BMO | 3.38 | 3.67 | +8.6% | 124.75 | -3.7% | -13.0% | +0.8% | -1.3% | +4.0% | -0.7% | — |
| Jul 31, 2025 | BMO | 3.36 | 3.73 | +11.0% | 113.91 | +8.1% | +4.9% | -3.0% | +0.1% | -1.0% | -2.4% | — |
| May 1, 2025 | BMO | 2.88 | 2.91 | +1.0% | 137.05 | -3.0% | -8.2% | +0.4% | -2.8% | -1.9% | +1.3% | — |
| Feb 27, 2025 | BMO | 3.86 | 3.89 | +0.8% | 177.63 | -11.9% | -21.7% | -4.6% | +1.8% | -3.2% | +2.6% | — |
| Oct 31, 2024 | BMO | 3.38 | 3.49 | +3.3% | 235.22 | -11.8% | -14.5% | +5.0% | -1.8% | -1.8% | -0.8% | — |
| Aug 1, 2024 | BMO | 3.33 | 3.42 | +2.7% | 220.92 | +2.6% | +6.8% | +0.5% | -1.6% | -1.1% | -2.4% | — |
| May 2, 2024 | BMO | 3.07 | 3.21 | +4.6% | 211.54 | -1.5% | -6.1% | +2.2% | -1.0% | +0.3% | -0.5% | — |
| Feb 22, 2024 | BMO | 3.26 | 3.38 | +3.7% | 250.95 | -3.2% | -5.3% | +0.0% | -4.2% | -0.8% | -0.6% | — |
| Nov 2, 2023 | BMO | 3.27 | 3.64 | +11.3% | 187.51 | +2.4% | +11.6% | +0.9% | +0.9% | -3.9% | -2.1% | — |
| Aug 3, 2023 | BMO | 3.21 | 3.41 | +6.2% | 248.61 | -1.5% | -3.7% | -0.7% | +1.0% | -4.3% | -0.4% | — |
| May 4, 2023 | BMO | 2.97 | 3.09 | +4.0% | 272.12 | -4.1% | -8.5% | +3.6% | +0.5% | -2.8% | -1.0% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 8 | Piper Sandler | Upgrade | Neutral → Overweight | $160 | $129.84 | $132.61 | +2.1% | +1.5% | +3.0% | -2.7% | -2.1% | +0.9% |
| May 8 | RBC Capital Mkts | Upgrade | Sector Perform → Outperform | $155 | $131.68 | $134.33 | +2.0% | +1.0% | -2.5% | -0.5% | +0.8% | +0.2% |
| Mar 27 | Raymond James | Upgrade | Market Perform → Outperform | — | $110.49 | $114.54 | +3.7% | +5.2% | -1.1% | +4.1% | -1.0% | -0.5% |
| Feb 27 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $119.02 | $117.72 | -1.1% | +2.6% | +0.7% | -0.6% | -2.5% | -1.4% |
| Feb 27 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $119.02 | $117.72 | -1.1% | +2.6% | +0.7% | -0.6% | -2.5% | -1.4% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $111.89 | $108.54 | -3.0% | +6.4% | +2.6% | +0.7% | -0.6% | -2.5% |
| Jan 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $105.33 | $104.71 | -0.6% | +0.1% | -1.1% | -1.0% | -1.0% | +3.5% |
| Jan 27 | Needham | Upgrade | Hold → Buy | — | $104.20 | $104.89 | +0.7% | +0.3% | +0.8% | +0.1% | -1.1% | -1.0% |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $125.10 | $125.00 | -0.1% | -0.5% | -2.1% | +2.1% | -1.8% | +0.0% |
| Dec 10 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $131.25 | $130.75 | -0.4% | -0.6% | -2.5% | -0.3% | -0.1% | -1.5% |
| Nov 10 | Truist | Maintains | Hold → Hold | — | $109.40 | $110.00 | +0.5% | -1.3% | +4.0% | -0.7% | -1.8% | -2.2% |
| Nov 7 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $108.51 | $108.29 | -0.2% | +0.8% | -1.3% | +4.0% | -0.7% | -1.8% |
| Nov 7 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $108.51 | $108.29 | -0.2% | +0.8% | -1.3% | +4.0% | -0.7% | -1.8% |
| Aug 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $119.50 | $119.35 | -0.1% | -3.0% | +0.1% | -1.0% | -2.4% | +3.1% |
| Aug 1 | Mizuho | Maintains | Neutral → Neutral | — | $119.50 | $119.35 | -0.1% | -3.0% | +0.1% | -1.0% | -2.4% | +3.1% |
| Aug 1 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $119.50 | $119.35 | -0.1% | -3.0% | +0.1% | -1.0% | -2.4% | +3.1% |
| Jul 16 | Mizuho | Maintains | Neutral → Neutral | — | $113.47 | $114.01 | +0.5% | -0.1% | +0.2% | -2.2% | -1.1% | +4.9% |
| Jul 15 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $115.75 | $116.01 | +0.2% | -2.0% | -0.1% | +0.2% | -2.2% | -1.1% |
| May 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $126.41 | $126.40 | -0.0% | -2.8% | -1.9% | +1.3% | +3.4% | -0.8% |
| May 5 | Truist | Maintains | Hold → Hold | — | $126.41 | $126.40 | -0.0% | -2.8% | -1.9% | +1.3% | +3.4% | -0.8% |
| May 2 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $125.87 | $128.55 | +2.1% | +0.4% | -2.8% | -1.9% | +1.3% | +3.4% |
| May 2 | RBC Capital | Maintains | Sector Perform → Sector Perform | — | $125.87 | $128.55 | +2.1% | +0.4% | -2.8% | -1.9% | +1.3% | +3.4% |
| Apr 11 | Truist | Maintains | Hold → Hold | — | $129.07 | $129.10 | +0.0% | +0.6% | +1.7% | -2.7% | -0.2% | +1.0% |
| Apr 2 | Citizens Capital Markets | Maintains | Market Perform → Market Perform | — | $140.30 | $139.47 | -0.6% | +0.8% | -2.4% | -4.4% | -0.9% | -2.7% |
| Mar 12 | Needham | Maintains | Hold → Hold | — | $138.82 | $138.55 | -0.2% | -2.4% | +0.6% | +1.0% | +1.5% | +0.2% |
| Mar 5 | Morgan Stanley | Maintains | Overweight → Overweight | — | $130.79 | $130.96 | +0.1% | +2.6% | +1.6% | +2.6% | -1.0% | +0.3% |
| Mar 4 | BofA Securities | Downgrade | Neutral → Underperform | — | $135.13 | $134.57 | -0.4% | -3.2% | +2.6% | +1.6% | +2.6% | -1.0% |
| Mar 3 | Truist | Maintains | Hold → Hold | — | $132.75 | $134.21 | +1.1% | +1.8% | -3.2% | +2.6% | +1.6% | +2.6% |
| Feb 28 | Piper Sandler | Downgrade | Overweight → Neutral | — | $139.11 | $135.45 | -2.6% | -4.6% | +1.8% | -3.2% | +2.6% | +1.6% |
| Feb 28 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $139.11 | $135.45 | -2.6% | -4.6% | +1.8% | -3.2% | +2.6% | +1.6% |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $178.28 | $177.40 | -0.5% | -3.2% | +1.2% | +1.9% | +0.1% | -0.6% |
| Dec 16 | Needham | Maintains | Hold → Hold | — | $180.14 | $179.40 | -0.4% | -1.6% | +0.6% | -3.2% | +1.2% | +1.9% |
| Nov 4 | Truist | Maintains | Hold → Hold | — | $211.21 | $210.31 | -0.4% | -1.8% | -1.8% | -0.8% | -1.9% | -1.3% |
| Nov 1 | Mizuho | Maintains | Neutral → Neutral | — | $201.06 | $201.94 | +0.4% | +5.0% | -1.8% | -1.8% | -0.8% | -1.9% |
| Nov 1 | RBC Capital | Maintains | Outperform → Outperform | — | $201.06 | $201.94 | +0.4% | +5.0% | -1.8% | -1.8% | -0.8% | -1.9% |
| Oct 14 | Truist | Maintains | Hold → Hold | — | $236.03 | $236.20 | +0.1% | +0.6% | -0.8% | -0.1% | -0.4% | +2.5% |
| Oct 8 | RBC Capital | Maintains | Outperform → Outperform | — | $232.96 | $234.28 | +0.6% | +0.9% | -0.2% | +0.1% | +0.6% | +0.6% |
| Aug 6 | RBC Capital | Maintains | Outperform → Outperform | — | $233.33 | $234.14 | +0.3% | -1.1% | -2.4% | +2.1% | -0.2% | -0.6% |
| Aug 5 | Truist | Maintains | Hold → Hold | — | $237.13 | $232.89 | -1.8% | -1.6% | -1.1% | -2.4% | +2.1% | -0.2% |
| Aug 2 | RBC Capital | Maintains | Outperform → Outperform | — | $235.95 | $237.37 | +0.6% | +0.5% | -1.6% | -1.1% | -2.4% | +2.1% |
| Aug 2 | Stephens & Co. | Maintains | Overweight → Overweight | — | $235.95 | $237.37 | +0.6% | +0.5% | -1.6% | -1.1% | -2.4% | +2.1% |
| Jul 16 | Truist | Maintains | Hold → Hold | — | $219.84 | $220.69 | +0.4% | +4.3% | +0.4% | -4.4% | +0.7% | +0.4% |
| Jul 9 | Truist | Maintains | Hold → Hold | — | $211.73 | $212.55 | +0.4% | +3.0% | +1.2% | +1.8% | -1.8% | -0.3% |
| Jul 1 | Piper Sandler | Upgrade | Neutral → Overweight | — | $210.33 | $214.27 | +1.9% | +0.5% | -0.1% | +0.1% | +1.2% | -1.1% |
| May 3 | Truist | Maintains | Hold → Hold | — | $198.73 | $201.19 | +1.2% | +2.2% | -1.0% | +0.3% | -0.5% | +2.1% |
| Feb 23 | RBC Capital | Maintains | Outperform → Outperform | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.2% | -0.8% | -0.6% | -0.9% |
| Feb 23 | Truist | Maintains | Hold → Hold | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.2% | -0.8% | -0.6% | -0.9% |
| Feb 23 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $237.70 | $238.98 | +0.5% | +0.0% | -4.2% | -0.8% | -0.6% | -0.9% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $248.34 | $251.95 | +1.5% | +0.3% | -1.3% | -0.4% | +0.6% | +0.2% |
| Dec 22 | Truist | Maintains | Hold → Hold | — | $251.43 | $252.52 | +0.4% | -0.2% | +0.5% | -0.6% | -0.3% | -0.2% |
No insider trades available.
8-K
Teleflex Incorporated -- 8-K Filing
Jun 2
8-K · 8.01
!! High
Teleflex Incorporated -- 8-K 8.01: Material Event / Announcement
Jun 1
8-K
Teleflex Incorporated -- 8-K Filing
Teleflex extended its credit facilities maturity to May 2031, providing long-term financing flexibility through revolving credit and term loan agreements secured by substantial domestic and foreign subsidiary assets.
May 27
8-K · 2.02
!! High
Teleflex Incorporated -- 8-K 2.02: Earnings Results
Teleflex reported Q1 2026 financial results on May 7, 2026, disclosing its operational performance and financial condition for the quarter ended March 31, 2026.
May 7
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Teleflex's planned asset sales generating $1.8 billion for shareholder buybacks and debt reduction demonstrate management's commitment to value creation, supporting stock appreciation while strengthening the balance sheet.
Mar 27
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Teleflex's planned Acute Care and Urology division sale faces regulatory scrutiny with an HSR Second Request, potentially delaying the transaction and creating uncertainty around deal completion timing and valuation.
Mar 17
8-K · 7.01
! Medium
Teleflex Incorporated -- 8-K 7.01: Regulation FD Disclosure
Teleflex's voluntary disclosure suggests management is proactively communicating material information to investors, potentially signaling confidence in operations or addressing market concerns that could impact stock valuation.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 4,998,850 | $610M | Reduced | Dec 2025 |
| 2 | Janus Henderson Group Plc | 4,291,311 | $513M | New | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 2,438,183 | $292M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 1,983,824 | $237M | New | Mar 2026 |
| 5 | Baupost Group Llc/ma | 1,595,000 | $191M | New | Mar 2026 |
| 6 | Citadel Advisors Llc | 1,171,096 | $140M | Added | Mar 2026 |
| 7 | Cooke & Bieler Lp | 1,142,674 | $137M | Reduced | Mar 2026 |
| 8 | River Road Asset Management, Llc | 922,116 | $110M | New | Mar 2026 |
| 9 | Irenic Capital Management Lp | 870,000 | $104M | New | Mar 2026 |
| 10 | Pzena Investment Management Llc | 699,125 | $84M | Added | Mar 2026 |
| 11 | Millennium Management | 682,058 | $82M | Added | Mar 2026 |
| 12 | Point72 Asset Management | 677,308 | $81M | New | Mar 2026 |
| 13 | Arrowstreet Capital, Limited Partnership | 638,761 | $76M | Reduced | Mar 2026 |
| 14 | Bank Of America Corp /de/ | 445,958 | $53M | Reduced | Mar 2026 |
| 15 | Diamond Hill Capital Management Inc | 349,809 | $43M | Added | Dec 2025 |
| 16 | Northern Trust Corp | 296,721 | $35M | Added | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 263,101 | $31M | — | Mar 2026 |
| 18 | Principal Financial Group Inc | 209,979 | $26M | Reduced | Dec 2025 |
| 19 | Ubs Group Ag | 197,347 | $24M | Reduced | Mar 2026 |
| 20 | Western Standard Llc | 184,817 | $22M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$5.62B
Enterprise Value
$7.83B
P/E (TTM)
-6.27x
Forward P/E
18.90x
PEG Ratio
0.00x
P/B
1.81x
P/S
2.85x
P/FCF
23.14x
EV/EBITDA
25.88x
Shares Out
44.7M
Financials (TTM)
Revenue
$1.99B
Net Income
-$905.6M
EBITDA
$302.5M
Free Cash Flow
$245.4M
Op Cash Flow
$340.7M
EPS Basic
$-20.30
EPS Diluted
$-20.25
EPS Forward
$6.72
Gross Margin
56.2%
Op Margin
12.8%
Net Margin
-45.5%
Balance Sheet
Total Assets
$6.95B
Total Liab.
$3.82B
Total Equity
$3.12B
Cash
$393.3M
LT Debt
$2.54B
Book Value/Sh
$70.03
Debt/Equity
0.87x
Current Ratio
2.54
Quick Ratio
2.01
Returns & Growth
ROE
-22.9%
ROA
-10.3%
ROIC
4.1%
Rev Growth YoY
-34.6%
EPS Growth YoY
-1462.4%
Price Returns
2W
-1.3%
1M
+3.8%
3M
+5.4%
6M
+12.4%
12M
+5.2%
Technicals
52W High
$139.67
52W Low
$100.18
50d MA
$129.33
200d MA
$120.24
RSI (14)
47.60
ATR (14)
$3.76
Beta
0.83
Avg Volume
663K
Dividends
Div Rate
$1.35
Div Yield
1.1%
Frequency
4
Ex-Div Date
Mar 6, 2026
Analyst Price Targets
Consensus
$132.20
High
$147.00
Low
$116.00
Median
$135.00
Data updated apr 27, 2026 4:34am
· Source: financialmodelingprep.com